4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001209191-18-047937
Chief Executive Officer sold 7,800 shares at an average $36.37 ($283,647)
From the SEC's structured data for this filing
Trades in this filing
Ciechanover Isaac E. · Chief Executive Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2018-08-20 | Sale : show line 1 in the form | −3,900 | $36.04 | $140,556 | 78,178 | I |
| 2018-08-21 | Sale : show line 2 in the form | −3,900 | $36.69 | $143,091 | 74,278 | I |
| Open-market sales · 7,800 sh · avg $36.37 · $283,647 | ||||||
Loading xslF345X03/doc4.xml…